Cambridge Investment Research Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.2M | Sell |
214,619
-1,011
| -0.5% | -$90.2K | 0.05% | 385 |
|
|
2026
Q1 | $15.5M | Buy |
215,630
+2,420
| +1% | +$186K | 0.04% | 455 |
|
|
2025
Q4 | $16.9M | Buy |
213,210
+9,721
| +5% | +$766K | 0.04% | 416 |
|
|
2025
Q3 | $15.3M | Sell |
203,489
-1,518
| -0.7% | -$104K | 0.04% | 434 |
|
|
2025
Q2 | $14.1M | Buy |
205,007
+9,136
| +5% | +$599K | 0.04% | 426 |
|
|
2025
Q1 | $13.3M | Sell |
195,871
-4,663
| -2% | -$279K | 0.04% | 411 |
|
|
2024
Q4 | $9M | Sell |
200,534
-15,239
| -7% | -$855K | 0.03% | 528 |
|
|
2024
Q3 | $13.6M | Sell |
215,773
-53,969
| -20% | -$3.15M | 0.05% | 396 |
|
|
2024
Q2 | $15.9M | Sell |
269,742
-61,356
| -19% | -$3.84M | 0.06% | 325 |
|
|
2024
Q1 | $26.4M | Sell |
331,098
-3,850
| -1% | -$294K | 0.1% | 185 |
|
|
2023
Q4 | $26.4M | Sell |
334,948
-35,049
| -9% | -$2.49M | 0.11% | 173 |
|
|
2023
Q3 | $25.8M | Sell |
369,997
-2,795
| -0.7% | -$198K | 0.12% | 166 |
|
|
2023
Q2 | $25.8M | Buy |
372,792
+32,341
| +9% | +$2.3M | 0.12% | 173 |
|
|
2023
Q1 | $25.3M | Buy |
340,451
+11,973
| +4% | +$1M | 0.12% | 171 |
|
|
2022
Q4 | $30.6M | Buy |
328,478
+8,421
| +3% | +$813K | 0.16% | 127 |
|
|
2022
Q3 | $30.5M | Sell |
320,057
-8,402
| -3% | -$832K | 0.17% | 110 |
|
|
2022
Q2 | $30.4M | Sell |
328,459
-14,778
| -4% | -$1.44M | 0.16% | 121 |
|
|
2022
Q1 | $34.7M | Buy |
343,237
+12,459
| +4% | +$1.31M | 0.16% | 120 |
|
|
2021
Q4 | $34.1M | Buy |
330,778
+4,045
| +1% | +$374K | 0.15% | 135 |
|
|
2021
Q3 | $27.7M | Sell |
326,733
-1,427
| -0.4% | -$120K | 0.14% | 158 |
|
|
2021
Q2 | $27.4M | Sell |
328,160
-3,430
| -1% | -$281K | 0.13% | 162 |
|
|
2021
Q1 | $24.9M | Buy |
331,590
+28,161
| +9% | +$2.05M | 0.14% | 160 |
|
|
2020
Q4 | $20.7M | Buy |
303,429
+55,259
| +22% | +$3.59M | 0.12% | 171 |
|
|
2020
Q3 | $14.5M | Sell |
248,170
-76,895
| -24% | -$4.78M | 0.1% | 211 |
|
|
2020
Q2 | $21.1M | Sell |
325,065
-7,986
| -2% | -$503K | 0.16% | 139 |
|
|
2020
Q1 | $19.8M | Buy |
333,051
+68,554
| +26% | +$4.58M | 0.19% | 115 |
|
|
2019
Q4 | $19.6M | Buy |
264,497
+5,391
| +2% | +$379K | 0.15% | 141 |
|
|
2019
Q3 | $16.3M | Buy |
259,106
+12,451
| +5% | +$738K | 0.14% | 152 |
|
|
2019
Q2 | $13.4M | Buy |
246,655
+55,013
| +29% | +$2.96M | 0.12% | 172 |
|
|
2019
Q1 | $10.3M | Sell |
191,642
-5,107
| -3% | -$315K | 0.1% | 200 |
|
|
2018
Q4 | $12.9M | Buy |
196,749
+41,905
| +27% | +$3.13M | 0.14% | 151 |
|
|
2018
Q3 | $12.2M | Buy |
154,844
+20,389
| +15% | +$1.46M | 0.12% | 172 |
|
|
2018
Q2 | $8.65M | Buy |
134,455
+7,038
| +6% | +$464K | 0.09% | 210 |
|
|
2018
Q1 | $7.93M | Buy |
127,417
+7,629
| +6% | +$547K | 0.09% | 224 |
|
|
2017
Q4 | $8.69M | Buy |
119,788
+4,638
| +4% | +$337K | 0.1% | 194 |
|
|
2017
Q3 | $9.36M | Buy |
115,150
+2,347
| +2% | +$186K | 0.13% | 155 |
|
|
2017
Q2 | $9.08M | Buy |
112,803
+6,389
| +6% | +$504K | 0.13% | 145 |
|
|
2017
Q1 | $8.35M | Buy |
106,414
+38,460
| +57% | +$3.07M | 0.14% | 132 |
|
|
2016
Q4 | $5.36M | Buy |
67,954
+6,811
| +11% | +$551K | 0.1% | 193 |
|
|
2016
Q3 | $5.44M | Sell |
61,143
-1,015
| -2% | -$95.8K | 0.1% | 182 |
|
|
2016
Q2 | $5.95M | Sell |
62,158
-239
| -0.4% | -$23.8K | 0.13% | 146 |
|
|
2016
Q1 | $6.47M | Buy |
62,397
+2,821
| +5% | +$274K | 0.15% | 129 |
|
|
2015
Q4 | $5.83M | Buy |
59,576
+6,727
| +13% | +$659K | 0.14% | 140 |
|
|
2015
Q3 | $5.1M | Buy |
52,849
+317
| +0.6% | +$33.3K | 0.15% | 140 |
|
|
2015
Q2 | $5.51M | Buy |
52,532
+6,609
| +14% | +$675K | 0.15% | 141 |
|
|
2015
Q1 | $4.74M | Buy |
45,923
+480
| +1% | +$48.6K | 0.13% | 153 |
|
|
2014
Q4 | $4.38M | Buy |
45,443
+4,194
| +10% | +$370K | 0.14% | 148 |
|
|
2014
Q3 | $3.28M | Buy |
41,249
+2,519
| +7% | +$199K | 0.1% | 200 |
|
|
2014
Q2 | $2.92M | Buy |
38,730
+1,717
| +5% | +$130K | 0.1% | 194 |
|
|
2014
Q1 | $2.77M | Buy |
37,013
+3,778
| +11% | +$267K | 0.1% | 183 |
|
|
2013
Q4 | $2.38M | Buy |
33,235
+1,276
| +4% | +$82K | 0.1% | 192 |
|
|
2013
Q3 | $1.81M | Sell |
31,959
-841
| -3% | -$50.1K | 0.08% | 237 |
|
|
2013
Q2 | $1.88M | Buy |
+32,800
| New | +$1.9M | 0.1% | 206 |
|
Other funds holding CVS
Cambridge Investment Research Advisors's CVS Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its CVS Health (CVS) stake by 0.47% in Q2 2026, selling an estimated $90.2K and leaving 214,619 shares worth $22.2M. The position accounts for 0.05% of the portfolio, ranked #385.
Cambridge Investment Research Advisors first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $34.7M in Q1 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Cambridge Investment Research Advisors held 214,619 shares of CVS Health worth $22.2M as of Q2 2026.
- Cambridge Investment Research Advisors sold 1,011 CVS Health shares in Q2 2026, an estimated $90.2K.
- CVS Health made up 0.05% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #385 holding.
- Cambridge Investment Research Advisors first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Cambridge Investment Research Advisors's CVS Health position peaked at $34.7M in Q1 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.